NXRT Q1 2026 Earnings BetterthanExpected Loss as Operational Efficiencies Drive Surprise VirnetX VHC Q2 2025 Earnings Narrowing Loss on Zero Revenue Stock Edges Lower Fulcrum Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances POOL Q1 2026 Earnings EPS Beats Estimates as Demand Holds Steady MGA Q1 2026 Earnings Strong EPS Beat of 33 Propels Stock Higher SEMR Q4 2025 Earnings EPS Falls Short of Consensus Revenue Figures Unavailable